hematology影响因子Hematology在2022-2023年的影响因子为1.9分。 Hematology影响因子的定义与计算方法 影响因子(Impact Factor, IF)是汤森路透出品的期刊引证报告(Journal Citation Reports, JCR)中的一项数据,用于衡量学术期刊的影响力。它定义为某期刊前两年发表的论文在该报告年份中被引用...
Journal Impact Factor 1 BLOOD 165,117 17.543 2 CIRCULATION RESEARCH 51,539 14.467 3 Journal of Hematology & Oncology 6,732 11.059 4 Lancet Haematology 2,446 10.406 5 LEUKEMIA 25,819 8.665 6 Blood Cancer Journal 2,800 8.023 7 HAEMATOLOGICA 17,314 7.116 8 AMERICAN JOURNAL OF HEMATOLOGY 10,629...
documents published in that journal. The chart shows the evolution of the average number of times documents published in a journal in the past two, three and four years have been cited in the current year. The two years line is equivalent to journal impact factor ™ (Thomson Reuters) ...
Journal of Hematology & Oncology operates a single-blind peer-review system, where the reviewers are aware of the names and affiliations of the authors, but the reviewer reports provided to authors are anonymous. The benefit of single-blind peer review is that it is the traditional model of pe...
We recorded the number of publications, clinical trials, randomized controlled trials, meta-analyses, case reports, reviews, citations, impact factors, articles in the top 10 journals and most published journals to assess the quantity and quality of research output in each region. Results A total...
Case Reports are invite only and pre-submission enquiries will not be considered. We recommend authors interested in submitting a non-invited Case Report consider the Journal of Medical Case Reports for their paper instead. Experimental Hematology & Oncology welcomes well-described reports of cases tha...
汤森路透每年出版一本《期刊引用报告》(Journal Citation Reports,简称JCR)。JCR对86000多种SCI期刊的影响因子(Impact Factor)等指数加以统计。JCR将收录期刊分为176个不同学科类别在JCR的Journal Ranking中,主要参考当年IF,最终每个分区的期刊数量是均分的。
This study investigated the efficacy of tisagenlecleucel (tisa-cel) and allogeneic hematopoietic stem cell transplantation (allo-SCT) for patients with relapsed and/or refractory (r/r) large B-cell lymphoma (LBCL) with poor prognostic factors, defined as performance status (PS)鈮 2, multiple ...
Annals of Hematology & Oncology accepts original research articles, review articles, case reports, mini reviews, rapid communication, opinions and editorials on all the related aspects of hematology and oncology. Review ArticlePublished: December 12, 2024 ...
the journal includes reports on results of clinical trials, which help foster communication among researchers in the growing field of modern hematology. The journal provides the best of up-to-date information on modern hematology, presenting readers with high-impact, original work focusing on pivotal...